The Enterprise Value as of December 2025 (TTM) for bioAffinity Technologies, Inc. (BIAF) is 7.60M

According to bioAffinity Technologies, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 7.60M. This represents a change of -39.52% compared to the average of 12.57M of the last 4 quarters.

bioAffinity Technologies, Inc. (BIAF) Historical Enterprise Value (quarterly & annually)

How has BIAF Enterprise Value performed in the past?

The mean historical Enterprise Value of bioAffinity Technologies, Inc. over the last ten years is 37.69M. The current 7.60M Enterprise Value has changed 1.92% with respect to the historical average. Over the past ten years (40 quarters), BIAF's Enterprise Value was at its highest in in the June 2022 quarter at 33.27M. The Enterprise Value was at its lowest in in the September 2022 quarter at -449210.10.

bioAffinity Technologies, Inc. (BIAF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of bioAffinity Technologies, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

bioAffinity Technologies, Inc. (BIAF) Average Enterprise Value

How has BIAF Enterprise Value performed in the past?

The current Enterprise Value of bioAffinity Technologies, Inc. (BIAF) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

bioAffinity Technologies, Inc. (BIAF) Enterprise Value vs. Peers

How is BIAF’s Enterprise Value compared to its peers?

bioAffinity Technologies, Inc.’s Enterprise Value is greater than Artelo Biosciences, Inc. (2.99M), greater than GT Biopharma, Inc. (4.16M), greater than Mobile-health Network Solutions Class A Ordinary Shares (-615624.00), less than WORK Medical Technology Group Ltd. (14.07M), greater than Carisma Therapeutics, Inc. (1.75M), greater than Psyence Biomedical Ltd. (-4844216.00), greater than Revelation Biosciences, Inc. (-6784353.00), greater than Protagenic Therapeutics, Inc. (3.67M), greater than Lipella Pharmaceuticals Inc. (-1590260161.00), greater than Salarius Pharmaceuticals, Inc. (293.35K),

Build a custom stock screener for bioAffinity Technologies, Inc. (BIAF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like bioAffinity Technologies, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

bioAffinity Technologies, Inc. (BIAF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like bioAffinity Technologies, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.